Drug intelligence / Profile preview

5'-O-(L-Serylsulfamoyl)adenosine

Development stage
Unknown
Modality
Small Molecules
01

Overview

5'-O-(L-Serylsulfamoyl)adenosine is a synthetic small molecule analog of the aminoacyl adenylate intermediate formed during protein synthesis. It consists of an adenosine moiety linked via a stable sulfamoyl bond to an L-serine residue. This compound acts as a non-hydrolyzable mimic of seryl adenylate and functions as a potent inhibitor of seryl-tRNA synthetase (SerRS), an essential enzyme in protein translation that catalyzes the attachment of serine to its cognate tRNA. By occupying the active site of SerRS and mimicking the natural reaction intermediate, it blocks aminoacylation and thus inhibits protein synthesis. The compound is primarily used in biochemical research to study enzyme mechanisms and for structure-based drug design targeting aminoacyl-tRNA synthetases[1][9].

Other names
5'-O-(N-(L-SERYL)-SULFAMOYL)ADENOSINE(2S)-2-amino-1-(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)sulfonyl)amino)-3-hydroxypropan-1-one(2S)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}sulfonyl)amino]-3-hydroxypropan-1-one
02

Targets

aaRS (Aminoacyl-tRNA synthetase family)

Beyond the preview

Go deeper on 5'-O-(L-Serylsulfamoyl)adenosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-O-(L-Serylsulfamoyl)adenosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call